Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
about
Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer DementiaThe Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's DiseaseAPOE*E4 Is Associated with Gray Matter Loss in the Posterior Cingulate Cortex in Healthy Elderly Controls Subsequently Developing Subtle Cognitive Decline.Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis.Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
P2860
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@en
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@nl
type
label
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@en
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@nl
prefLabel
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@en
Cognition, brain atrophy, and ...... influence of apolipoprotein e.
@nl
P356
P1476
Cognition, brain atrophy, and ...... influence of apolipoprotein e
@en
P2093
Alzheimer’s Disease Neuroimaging Initiative
Thomas Adi Kurnia Susanto
P304
P356
10.3233/JAD-142451
P577
2015-01-01T00:00:00Z